ZA902912B - Method of inhibiting induction of latent or chronic viral infection - Google Patents

Method of inhibiting induction of latent or chronic viral infection

Info

Publication number
ZA902912B
ZA902912B ZA902912A ZA902912A ZA902912B ZA 902912 B ZA902912 B ZA 902912B ZA 902912 A ZA902912 A ZA 902912A ZA 902912 A ZA902912 A ZA 902912A ZA 902912 B ZA902912 B ZA 902912B
Authority
ZA
South Africa
Prior art keywords
latent
viral infection
chronic viral
inhibiting induction
inhibiting
Prior art date
Application number
ZA902912A
Inventor
Jeffrey Laurence
Laurence Jeffrey
O P Ts O Paul
Paul S Miller
S Miller Paul
Original Assignee
Cornell Res Foundation Inc
Univ Johns Hopkins
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cornell Res Foundation Inc, Univ Johns Hopkins filed Critical Cornell Res Foundation Inc
Publication of ZA902912B publication Critical patent/ZA902912B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • C12N15/1131—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against viruses
    • C12N15/1132—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against viruses against retroviridae, e.g. HIV
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701—Specific hybridization probes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/30—Chemical structure
    • C12N2310/31—Chemical structure of the backbone
    • C12N2310/312—Phosphonates
    • C12N2310/3125—Methylphosphonates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/30—Chemical structure
    • C12N2310/35—Nature of the modification
    • C12N2310/351—Conjugate
    • C12N2310/3517—Marker; Tag

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Plant Pathology (AREA)
  • AIDS & HIV (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Analytical Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
ZA902912A 1989-04-21 1990-04-18 Method of inhibiting induction of latent or chronic viral infection ZA902912B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US34150889A 1989-04-21 1989-04-21

Publications (1)

Publication Number Publication Date
ZA902912B true ZA902912B (en) 1991-01-30

Family

ID=23337878

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA902912A ZA902912B (en) 1989-04-21 1990-04-18 Method of inhibiting induction of latent or chronic viral infection

Country Status (7)

Country Link
EP (1) EP0469080A4 (en)
JP (1) JPH04505615A (en)
KR (1) KR920700654A (en)
AU (2) AU5551190A (en)
CA (1) CA2014990A1 (en)
WO (1) WO1990012578A1 (en)
ZA (1) ZA902912B (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0402402B1 (en) * 1988-02-26 1995-12-27 Worcester Foundation For Biomedical Research, Inc. Inhibition of htlv-iii by exogenous oligonucleotides
CA2105595A1 (en) * 1992-09-23 1994-03-24 Ramaswamy Narayanan Antisense polynucleotides
US6776986B1 (en) 1996-06-06 2004-08-17 Novartis Ag Inhibition of HIV-1 replication by antisense RNA expression
US6831057B2 (en) 1997-10-28 2004-12-14 The University Of North Carolina At Chapel Hill Use of NF-κB inhibition in combination therapy for cancer
WO2002092006A2 (en) * 2001-05-16 2002-11-21 Micrologix Biotech, Inc. Nucleic acid-based compounds and methods of use thereof
RU2207876C1 (en) * 2001-11-08 2003-07-10 Ткаченко Виталий Васильевич Method for complex- individualized impact upon body at slow viral infection and method for preparing laboratory animal for testing the method of such impact

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4757055A (en) * 1980-11-12 1988-07-12 The Johns Hopkins University Method for selectively controlling unwanted expression or function of foreign nucleic acids in animal or mammalian cells
US4511713A (en) * 1980-11-12 1985-04-16 The Johns Hopkins University Process for selectively controlling unwanted expression or function of foreign nucleic acids in animal or mammalian cells
US4469863A (en) * 1980-11-12 1984-09-04 Ts O Paul O P Nonionic nucleic acid alkyl and aryl phosphonates and processes for manufacture and use thereof
US4806463A (en) * 1986-05-23 1989-02-21 Worcester Foundation For Experimental Biology Inhibition of HTLV-III by exogenous oligonucleotides

Also Published As

Publication number Publication date
EP0469080A4 (en) 1992-04-29
AU6465194A (en) 1994-10-06
KR920700654A (en) 1992-08-10
AU5551190A (en) 1990-11-16
EP0469080A1 (en) 1992-02-05
JPH04505615A (en) 1992-10-01
CA2014990A1 (en) 1990-10-21
WO1990012578A1 (en) 1990-11-01

Similar Documents

Publication Publication Date Title
GB2280606B (en) Physical forms of benzenesulphonamides
EP0242038A3 (en) Magnetic induction hearing aid
DK0421655T3 (en) induction
ZA906621B (en) Use of viruses against undesirable micro-organisms
DK0421656T3 (en) induction
IL82420A0 (en) Method of detecting aids virus infection
EP0608212A4 (en) Method of treating viral infection.
EP0457175A3 (en) Method of purification of alkoxysilanes
PH24087A (en) Method of inhibiting the transmission of aids virus
ZA902912B (en) Method of inhibiting induction of latent or chronic viral infection
EP0610444A4 (en) Method of treating viral diseases.
EP0405922A3 (en) Method of demodulation
EP0546261A3 (en) Method of treating latent herpes viral infections
EP0472595A4 (en) Method of treatment of hepatitis
FI92008B (en) Induction hob or hob
EP0472663A4 (en) Method of treatment of hepatitis
GB9006924D0 (en) Prognosis of hepatitis infection
ZA889498B (en) Method of inhibiting virus
ZA889496B (en) Method of inhibiting virus
RU1832331C (en) Method of modelling persistent viral infection
ZM8088A1 (en) Method of inhibiting virus
ZM7988A1 (en) Method of inhibiting virus
ZA904825B (en) Inhibition of potato-sprouting
GB8914680D0 (en) Prevention of aid virus
IE892878L (en) Method of treating viral infections